Epidemiology of asthma: Prevalence and burden of disease

Research output: Chapter in Book/Report/Conference proceedingChapter

53 Citations (Scopus)

Abstract

While clinical guidelines clearly define mechanisms for asthma diagnosis based upon history, lung function testing, symptoms, and physical examination, surveillance for asthma is much less straightforward. Epidemiologists have long debated the best means of assessing the scope and burden of asthma, seeking to reduce the potential for confounding introduced by differential means of diagnosis and even slight differences in surveillance questions, both of which can bias surveillance results such that we over-or undercount cases. This chapter will provide an overview of asthma epidemiology in the USA and internationally, as well as review of the data and findings from the major surveillance systems, a discussion of a networked approach to the science and evaluation of therapeutic treatments using the exemplar of the Inner-City Asthma Network, and assessment of public health implications.

Original languageEnglish (US)
Title of host publicationAdvances in Experimental Medicine and Biology
PublisherSpringer New York LLC
Pages17-29
Number of pages13
Volume795
ISBN (Print)9781461486022
DOIs
StatePublished - 2014

Publication series

NameAdvances in Experimental Medicine and Biology
Volume795
ISSN (Print)00652598

Fingerprint

Epidemiology
Asthma
Public health
Testing
Physical Examination
Differential Diagnosis
Public Health
History
Guidelines
Lung
Therapeutics

Keywords

  • Asthma prevalence
  • Clinical guidelines
  • Epidemiology
  • Public health
  • Surveillance

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Croisant, S. (2014). Epidemiology of asthma: Prevalence and burden of disease. In Advances in Experimental Medicine and Biology (Vol. 795, pp. 17-29). (Advances in Experimental Medicine and Biology; Vol. 795). Springer New York LLC. https://doi.org/10.1007/978-1-4614-8603-9_2

Epidemiology of asthma : Prevalence and burden of disease. / Croisant, Sharon.

Advances in Experimental Medicine and Biology. Vol. 795 Springer New York LLC, 2014. p. 17-29 (Advances in Experimental Medicine and Biology; Vol. 795).

Research output: Chapter in Book/Report/Conference proceedingChapter

Croisant, S 2014, Epidemiology of asthma: Prevalence and burden of disease. in Advances in Experimental Medicine and Biology. vol. 795, Advances in Experimental Medicine and Biology, vol. 795, Springer New York LLC, pp. 17-29. https://doi.org/10.1007/978-1-4614-8603-9_2
Croisant S. Epidemiology of asthma: Prevalence and burden of disease. In Advances in Experimental Medicine and Biology. Vol. 795. Springer New York LLC. 2014. p. 17-29. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-1-4614-8603-9_2
Croisant, Sharon. / Epidemiology of asthma : Prevalence and burden of disease. Advances in Experimental Medicine and Biology. Vol. 795 Springer New York LLC, 2014. pp. 17-29 (Advances in Experimental Medicine and Biology).
@inbook{6e8c70d0c2f44c1a85efd66cff5be397,
title = "Epidemiology of asthma: Prevalence and burden of disease",
abstract = "While clinical guidelines clearly define mechanisms for asthma diagnosis based upon history, lung function testing, symptoms, and physical examination, surveillance for asthma is much less straightforward. Epidemiologists have long debated the best means of assessing the scope and burden of asthma, seeking to reduce the potential for confounding introduced by differential means of diagnosis and even slight differences in surveillance questions, both of which can bias surveillance results such that we over-or undercount cases. This chapter will provide an overview of asthma epidemiology in the USA and internationally, as well as review of the data and findings from the major surveillance systems, a discussion of a networked approach to the science and evaluation of therapeutic treatments using the exemplar of the Inner-City Asthma Network, and assessment of public health implications.",
keywords = "Asthma prevalence, Clinical guidelines, Epidemiology, Public health, Surveillance",
author = "Sharon Croisant",
year = "2014",
doi = "10.1007/978-1-4614-8603-9_2",
language = "English (US)",
isbn = "9781461486022",
volume = "795",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer New York LLC",
pages = "17--29",
booktitle = "Advances in Experimental Medicine and Biology",

}

TY - CHAP

T1 - Epidemiology of asthma

T2 - Prevalence and burden of disease

AU - Croisant, Sharon

PY - 2014

Y1 - 2014

N2 - While clinical guidelines clearly define mechanisms for asthma diagnosis based upon history, lung function testing, symptoms, and physical examination, surveillance for asthma is much less straightforward. Epidemiologists have long debated the best means of assessing the scope and burden of asthma, seeking to reduce the potential for confounding introduced by differential means of diagnosis and even slight differences in surveillance questions, both of which can bias surveillance results such that we over-or undercount cases. This chapter will provide an overview of asthma epidemiology in the USA and internationally, as well as review of the data and findings from the major surveillance systems, a discussion of a networked approach to the science and evaluation of therapeutic treatments using the exemplar of the Inner-City Asthma Network, and assessment of public health implications.

AB - While clinical guidelines clearly define mechanisms for asthma diagnosis based upon history, lung function testing, symptoms, and physical examination, surveillance for asthma is much less straightforward. Epidemiologists have long debated the best means of assessing the scope and burden of asthma, seeking to reduce the potential for confounding introduced by differential means of diagnosis and even slight differences in surveillance questions, both of which can bias surveillance results such that we over-or undercount cases. This chapter will provide an overview of asthma epidemiology in the USA and internationally, as well as review of the data and findings from the major surveillance systems, a discussion of a networked approach to the science and evaluation of therapeutic treatments using the exemplar of the Inner-City Asthma Network, and assessment of public health implications.

KW - Asthma prevalence

KW - Clinical guidelines

KW - Epidemiology

KW - Public health

KW - Surveillance

UR - http://www.scopus.com/inward/record.url?scp=84934443635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84934443635&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-8603-9_2

DO - 10.1007/978-1-4614-8603-9_2

M3 - Chapter

C2 - 24162900

AN - SCOPUS:84934443635

SN - 9781461486022

VL - 795

T3 - Advances in Experimental Medicine and Biology

SP - 17

EP - 29

BT - Advances in Experimental Medicine and Biology

PB - Springer New York LLC

ER -